{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherID": [], "KeywordList": [["Centella asiatica (L.) Urb.", "Eclipta prostrata (L.) L.", "Hypertension", "Network pharmacology", "Smilax glabra Roxb."]], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "GeneralNote": [], "PMID": "34627325", "DateRevised": {"Year": "2021", "Month": "10", "Day": "22"}, "Article": {"ELocationID": ["10.1186/s13020-021-00507-1"], "ArticleDate": [{"Year": "2021", "Month": "10", "Day": "09"}], "Language": ["eng"], "Journal": {"ISSN": "1749-8546", "JournalIssue": {"Volume": "16", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Oct", "Day": "09"}}, "Title": "Chinese medicine", "ISOAbbreviation": "Chin Med"}, "ArticleTitle": "A network pharmacology-based approach to explore the active ingredients and molecular mechanism of Lei-gong-gen formula granule on a spontaneously hypertensive rat model.", "Pagination": {"MedlinePgn": "99"}, "Abstract": {"AbstractText": ["Lei-gong-gen formula granule (LFG) is a folk prescription derived from Zhuang nationality, the largest ethnic minority among 56 nationalities in China. It consists of three herbs, namely Eclipta prostrata (L.) L., Smilax glabra Roxb, and Centella asiatica (L.) Urb. It has been widely used as health protection tea for hundreds of years to prevent hypertension in Guangxi Zhuang Autonomous Region. The purpose of this study is to validate the antihypertensive effect of LFG on the spontaneously hypertensive rat (SHR) model, and to further identify the effective components and anti-hypertension mechanism of LFG.", "The effects of LFG on blood pressure, body weight, and heart rate were investigated in vivo using the SHR model. The levels of NO, ANG II, and ET-1 in the serum were measured, and pathological changes in the heart were examined by H&E staining. The main active components of LFG, their corresponding targets, and hypertension associated pathways were discerned through network pharmacology analysis based on the Traditional Chinese Medicine Systems Pharmacology (TCMSP), Traditional Chinese Medicine Integrated Database (TCMID), and the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). Then the predicted results were further verified by molecular biology experiments such as RT-qPCR and western blot. Additionally, the potential active compounds were predicted by molecular docking technology, and the chemical constituents of LFG were analyzed and identified by UPLC-QTOF/MS technology. Finally, an in vitro assay was performed to investigate the protective effects of potential active compounds against hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) induced oxidative damage in human umbilical vein endothelial cells (HUVEC).", "LFG could effectively reduce blood pressure and increase serum NO content in SHR model. Histological results showed that LFG could ameliorate pathological changes such as cardiac hypertrophy and interstitial inflammation. From network pharmacology analysis, 53 candidate active compounds of LFG were collected, which linked to 765 potential targets, and 828 hypertension associated targets were retrieved, from which 12 overlapped targets both related to candidate active compounds from LFG and hypertension were screened and used as the potential targets of LFG on antihypertensive effect. The molecular biology experiments of the 12 overlapped targets showed that LFG could upregulate the mRNA and protein expressions of NOS3 and proto-oncogene tyrosine-protein kinase SRC (SRC) in the thoracic aorta. Pathway enrichment analysis showed that the PI3K-AKT signaling pathway was closely related to the expression of NOS3 and SRC. Moreover, western blot results showed that LFG significantly increased the protein expression levels of PI3K and phosphorylated AKT in SHR model, suggesting that LFG may active the PI3K-AKT signaling pathway to decrease hypertension. Molecular docking study further supported that p-hydroxybenzoic acid, cedar acid, shikimic acid, salicylic acid, nicotinic acid, linalool, and histidine can be well binding with NOS3, SRC, PI3K, and AKT. UPLC-QTOF/MS analysis confirmed that p-hydroxybenzoic acid, shikimic acid, salicylic acid, and nicotinic acid existed in LFG. Pre-treatment of HUVEC with nicotinic acid could alleviate the effect on cell viability induced by H<sub>2</sub>O<sub>2</sub> and increase the NO level in cell supernatants.", "LFG can reduce the blood pressure in SHR model, which might be attributed to increasing the NO level in serum for promoting vasodilation via upregulating SRC expression level and activating the PI3K-AKT-NOS3 signaling pathway. Nicotinic acid might be the potential compound for LFG antihypertensive effect."], "CopyrightInformation": "\u00a9 2021. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation & College of Pharmacy, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education & Center for Translational Medicine, School of preclinical medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China."}], "LastName": "Li", "ForeName": "Qiaofeng", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of preclinical medicine, Guangxi University of Chinese Medicine, 179 Mingxiu Dong Road, Nanning, 530001, China."}], "LastName": "Lan", "ForeName": "Taijin", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Institute for Food and Drug Control, 9 Qinghu Road, Nanning, 530021, China."}], "LastName": "He", "ForeName": "Songhua", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, 530021, China."}, {"Identifier": [], "Affiliation": "International Joint Laboratory on Regeneration of Bone and Soft Tissues, Guangxi Medical University, Guangxi, 530021, China."}], "LastName": "Chen", "ForeName": "Weiwei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation & College of Pharmacy, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education & Center for Translational Medicine, School of preclinical medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China."}], "LastName": "Li", "ForeName": "Xiaolan", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation & College of Pharmacy, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education & Center for Translational Medicine, School of preclinical medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China."}], "LastName": "Zhang", "ForeName": "Weiquan", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education & Center for Translational Medicine, School of preclinical medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guangxi University of Chinese Medicine, 179 Mingxiu Dong Road, Nanning, 530001, China."}], "LastName": "Liu", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education & Center for Translational Medicine, School of preclinical medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China."}, {"Identifier": [], "Affiliation": "The First Affiliated Hospital, Guangxi Medical University, 6 Shuangyong Road, Nanning, 530021, China."}], "LastName": "Zhang", "ForeName": "Qiuping", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation & College of Pharmacy, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education & Center for Translational Medicine, School of preclinical medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China."}], "LastName": "Chen", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation & College of Pharmacy, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education & Center for Translational Medicine, School of preclinical medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China."}], "LastName": "Han", "ForeName": "Yaoyao", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation & College of Pharmacy, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China. suzhiheng915@126.com."}], "LastName": "Su", "ForeName": "Zhiheng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation & College of Pharmacy, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China. zdgxmu2006@163.com."}], "LastName": "Zhu", "ForeName": "Dan", "Initials": "D"}, {"Identifier": ["http://orcid.org/0000-0002-4046-2643"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation & College of Pharmacy, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China. hongweiguo@gxmu.edu.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of Longevity and Aging-related Diseases of Chinese Ministry of Education & Center for Translational Medicine, School of preclinical medicine, Guangxi Medical University, Nanning, 530021, Guangxi, China. hongweiguo@gxmu.edu.cn."}, {"Identifier": [], "Affiliation": "Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, 530021, China. hongweiguo@gxmu.edu.cn."}], "LastName": "Guo", "ForeName": "Hongwei", "Initials": "H"}], "GrantList": [{"GrantID": "2020GXNSFAA259030", "Agency": "Guangxi Natural Science Foundation", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Chin Med", "NlmUniqueID": "101265109", "ISSNLinking": "1749-8546"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "J Ethnopharmacol. 2020 Oct 5;260:112989", "ArticleIdList": ["32526339"]}, {"Citation": "Chem Pharm Bull (Tokyo). 1996 Oct;44(10):1908-14", "ArticleIdList": ["8904818"]}, {"Citation": "Int Immunopharmacol. 2016 Oct;39:97-105", "ArticleIdList": ["27454847"]}, {"Citation": "Hypertens Res. 2013 Jul;36(7):570-9", "ArticleIdList": ["23552514"]}, {"Citation": "Hypertens Res. 2019 Aug;42(8):1099-1113", "ArticleIdList": ["30867575"]}, {"Citation": "Genome Res. 2003 Nov;13(11):2498-504", "ArticleIdList": ["14597658"]}, {"Citation": "Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1235-48", "ArticleIdList": ["20081107"]}, {"Citation": "Am J Kidney Dis. 2012 Jun;59(6):803-9", "ArticleIdList": ["22381643"]}, {"Citation": "Methods. 2001 Dec;25(4):402-8", "ArticleIdList": ["11846609"]}, {"Citation": "Clin Cosmet Investig Dermatol. 2015 Aug 26;8:455-61", "ArticleIdList": ["26347269"]}, {"Citation": "J Cheminform. 2014 Apr 16;6:13", "ArticleIdList": ["24735618"]}, {"Citation": "Appl Microbiol Biotechnol. 2017 Jul;101(13):5247-5257", "ArticleIdList": ["28623383"]}, {"Citation": "J Hypertens. 1995 Apr;13(4):385-95", "ArticleIdList": ["7629398"]}, {"Citation": "Int J Mol Sci. 2012;13(6):6964-82", "ArticleIdList": ["22837674"]}, {"Citation": "Complement Ther Med. 2017 Apr;31:90-99", "ArticleIdList": ["28434477"]}, {"Citation": "J Cardiovasc Pharmacol. 2006 Apr;47(4):531-41", "ArticleIdList": ["16680066"]}, {"Citation": "Naunyn Schmiedebergs Arch Pharmacol. 2012 Dec;385(12):1175-84", "ArticleIdList": ["23079793"]}, {"Citation": "Exp Cell Res. 1998 Oct 10;244(1):196-205", "ArticleIdList": ["9770362"]}, {"Citation": "Food Res Int. 2018 Apr;106:558-567", "ArticleIdList": ["29579961"]}, {"Citation": "JAMA. 2003 May 14;289(18):2363-9", "ArticleIdList": ["12746359"]}, {"Citation": "Int J Cardiol. 2007 Sep 3;120(3):317-24", "ArticleIdList": ["17240464"]}, {"Citation": "Zhongguo Zhong Yao Za Zhi. 2015 Oct;40(19):3718-22", "ArticleIdList": ["26975091"]}, {"Citation": "J Nutr Biochem. 2011 Jan;22(1):16-21", "ArticleIdList": ["20185287"]}, {"Citation": "J Biol Chem. 1999 Aug 27;274(35):25130-5", "ArticleIdList": ["10455194"]}, {"Citation": "BMC Complement Altern Med. 2009 Aug 04;9:27", "ArticleIdList": ["19653897"]}, {"Citation": "Environ Toxicol. 2018 Sep;33(9):923-930", "ArticleIdList": ["29962088"]}, {"Citation": "Br J Pharmacol. 2014 Aug;171(16):3895-907", "ArticleIdList": ["24779394"]}, {"Citation": "Eur J Pharmacol. 2010 Dec 15;649(1-3):301-13", "ArticleIdList": ["20868659"]}, {"Citation": "Nat Protoc. 2009;4(1):44-57", "ArticleIdList": ["19131956"]}, {"Citation": "J Am Soc Hypertens. 2012 May-Jun;6(3):169-78", "ArticleIdList": ["22341198"]}, {"Citation": "Biochem Pharmacol. 2018 May;151:38-46", "ArticleIdList": ["29454617"]}, {"Citation": "Hypertension. 2013 May;61(5):1028-35", "ArticleIdList": ["23478100"]}, {"Citation": "Evid Based Complement Alternat Med. 2014;2014:495840", "ArticleIdList": ["24527048"]}, {"Citation": "Bioengineered. 2013 Jul-Aug;4(4):244-8", "ArticleIdList": ["23579100"]}, {"Citation": "Life Sci. 2007 Sep 22;81(15):1193-8", "ArticleIdList": ["17889905"]}, {"Citation": "Biochim Biophys Acta. 2010 Jan;1800(1):6-15", "ArticleIdList": ["19878707"]}, {"Citation": "Sci Rep. 2017 Feb 22;7:42965", "ArticleIdList": ["28225023"]}, {"Citation": "Int J Cardiol. 2017 Jan 15;227:516-523", "ArticleIdList": ["27856040"]}, {"Citation": "Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2383-94", "ArticleIdList": ["21926342"]}, {"Citation": "Nucleic Acids Res. 2013 Jan;41(Database issue):D1089-95", "ArticleIdList": ["23203875"]}, {"Citation": "Clin Exp Hypertens. 1980;2(6):1083-96", "ArticleIdList": ["7004805"]}, {"Citation": "Bioinformatics. 2013 Jul 15;29(14):1827-9", "ArticleIdList": ["23712658"]}, {"Citation": "Microcirculation. 2004 Dec;11(8):689-97", "ArticleIdList": ["15726836"]}, {"Citation": "Pharmaceuticals (Basel). 2018 Oct 21;11(4):", "ArticleIdList": ["30347874"]}, {"Citation": "Cardiovasc Ther. 2012 Jun;30(3):e156-66", "ArticleIdList": ["21883995"]}, {"Citation": "Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613", "ArticleIdList": ["30476243"]}, {"Citation": "Am J Physiol Renal Physiol. 2009 Jul;297(1):F106-13", "ArticleIdList": ["19420110"]}, {"Citation": "J Biol Chem. 1980 Sep 25;255(18):8363-5", "ArticleIdList": ["6157683"]}, {"Citation": "Curr Opin Lipidol. 2004 Dec;15(6):659-65", "ArticleIdList": ["15529025"]}, {"Citation": "J Hypertens. 2012 Feb;30(2):315-26", "ArticleIdList": ["22179086"]}, {"Citation": "Chem Biol Interact. 2008 Jan 10;171(1):1-14", "ArticleIdList": ["17996228"]}, {"Citation": "Cell Signal. 2011 Jul;23(7):1136-43", "ArticleIdList": ["21385608"]}, {"Citation": "Biochim Biophys Acta. 2002 Jun 21;1602(2):114-30", "ArticleIdList": ["12020799"]}, {"Citation": "Phytomedicine. 2009 Apr;16(4):303-7", "ArticleIdList": ["18824339"]}, {"Citation": "Am J Physiol Regul Integr Comp Physiol. 2001 Sep;281(3):R944-50", "ArticleIdList": ["11507012"]}, {"Citation": "J Hypertens. 2011 Jul;29(7):1270-80", "ArticleIdList": ["21558959"]}, {"Citation": "Chin J Nat Med. 2013 Mar;11(2):110-20", "ArticleIdList": ["23787177"]}, {"Citation": "Clin Exp Pharmacol Physiol. 2015 Nov;42(11):1189-97", "ArticleIdList": ["26234646"]}, {"Citation": "Colloids Surf B Biointerfaces. 2018 Nov 1;171:566-578", "ArticleIdList": ["30098535"]}, {"Citation": "J Ethnopharmacol. 2015 Jul 1;169:435-40", "ArticleIdList": ["25926285"]}, {"Citation": "Database (Oxford). 2013 Feb 12;2013:bas061", "ArticleIdList": ["23406793"]}, {"Citation": "Biomed Pharmacother. 2018 Dec;108:547-557", "ArticleIdList": ["30243088"]}, {"Citation": "Sci Rep. 2016 Feb 16;6:21146", "ArticleIdList": ["26879404"]}, {"Citation": "Drug Discov Today. 2004 Oct 1;9(19):826-7", "ArticleIdList": ["15381132"]}, {"Citation": "Clin Exp Pharmacol Physiol. 2010 Jan;37(1):62-8", "ArticleIdList": ["19566844"]}, {"Citation": "J Ethnopharmacol. 2013 Jan 9;145(1):1-10", "ArticleIdList": ["23142198"]}, {"Citation": "Planta Med. 2019 Nov;85(16):1203-1215", "ArticleIdList": ["31539918"]}, {"Citation": "Complement Ther Med. 2015 Jun;23(3):484-93", "ArticleIdList": ["26051584"]}, {"Citation": "Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):556-63", "ArticleIdList": ["17170375"]}, {"Citation": "Mini Rev Med Chem. 2009 May;9(5):526-38", "ArticleIdList": ["19456284"]}, {"Citation": "Front Pharmacol. 2020 Mar 24;11:345", "ArticleIdList": ["32265716"]}]}], "History": [{"Year": "2021", "Month": "02", "Day": "17"}, {"Year": "2021", "Month": "09", "Day": "17"}, {"Year": "2021", "Month": "10", "Day": "10", "Hour": "20", "Minute": "33"}, {"Year": "2021", "Month": "10", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "11", "Hour": "6", "Minute": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["34627325", "10.1186/s13020-021-00507-1", "10.1186/s13020-021-00507-1", "PMC8501634"]}}]}